Total Payments
$4,653
2024 Payments
$1,056
Companies
27
Transactions
218
Medicare Patients
5,273
Medicare Billing
$876,177
Payment Breakdown by Category
Food & Beverage$4,641 (99.7%)
Consulting$12.10 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,641 | 217 | 99.7% |
| Consulting Fee | $12.10 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,498 | 49 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $615.55 | 33 | $0 (2024) |
| QOL Medical, LLC | $515.85 | 44 | $0 (2020) |
| Janssen Biotech, Inc. | $289.70 | 14 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $250.71 | 14 | $0 (2023) |
| Celgene Corporation | $215.75 | 17 | $0 (2024) |
| PFIZER INC. | $149.95 | 2 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $140.80 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $134.99 | 1 | $0 (2024) |
| Merz North America, Inc. | $125.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,056 | 22 | ABBVIE INC. ($547.78) |
| 2023 | $1,502 | 87 | AbbVie Inc. ($488.35) |
| 2022 | $136.26 | 8 | Celgene Corporation ($30.68) |
| 2021 | $27.16 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($14.68) |
| 2020 | $140.70 | 7 | QOL Medical, LLC ($87.24) |
| 2019 | $1,023 | 59 | QOL Medical, LLC ($332.79) |
| 2018 | $707.73 | 29 | AbbVie, Inc. ($292.83) |
| 2017 | $60.54 | 4 | Ironwood Pharmaceuticals, Inc ($47.77) |
All Payment Transactions
218 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Rare Disease | ||||||
| 11/06/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Rare Disease | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: Gastroenterology | ||||||
| 05/29/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.03 | General |
| Category: Neuroscience | ||||||
| 05/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/06/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 03/27/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Immunology | ||||||
| 03/20/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/20/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $134.99 | General |
| Category: Neuroscience | ||||||
| 03/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Gastroenterology | ||||||
| 02/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.20 | General |
| 01/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Gastroenterology | ||||||
| 12/20/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,896 | 2,457 | $1.1M | $231,473 |
| 2022 | 12 | 1,058 | 1,442 | $868,038 | $236,591 |
| 2021 | 13 | 1,054 | 1,450 | $722,821 | $213,201 |
| 2020 | 15 | 1,265 | 1,775 | $685,691 | $194,912 |
Total Patients
5,273
Total Services
7,124
Medicare Billing
$876,177
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 413 | 640 | $190,546 | $76,874 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 290 | 486 | $107,716 | $41,604 | 38.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 176 | 176 | $299,669 | $27,807 | 9.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 145 | 147 | $256,386 | $17,177 | 6.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $56,207 | $16,019 | 28.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 57 | 57 | $76,855 | $14,595 | 19.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 88 | 88 | $32,275 | $9,448 | 29.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $59,856 | $7,993 | 13.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 93 | $7,906 | $4,996 | 63.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 25 | $5,686 | $4,227 | 74.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $6,765 | $2,669 | 39.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 165 | 259 | $4,807 | $2,176 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $3,944 | $1,982 | 50.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 62 | 66 | $4,285 | $1,428 | 33.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 45 | 50 | $4,730 | $517.50 | 10.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 30 | $2,769 | $421.20 | 15.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 45 | 51 | $2,315 | $388.11 | 16.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 20 | 21 | $1,109 | $280.56 | 25.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 13 | 13 | $1,165 | $192.14 | 16.5% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 23 | 27 | $1,263 | $190.62 | 15.1% |
| 86141 | Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | Office | 2023 | 15 | 15 | $2,996 | $190.35 | 6.4% |
| 83550 | Iron binding capacity | Office | 2023 | 19 | 20 | $1,650 | $171.40 | 10.4% |
| 83540 | Iron level | Office | 2023 | 19 | 20 | $1,450 | $126.80 | 8.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 359 | 700 | $213,659 | $77,903 | 36.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 155 | 157 | $225,000 | $53,451 | 23.8% |
About Nathan Schulman
Nathan Schulman is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134296866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nathan Schulman has received a total of $4,653 in payments from pharmaceutical and medical device companies, with $1,056 received in 2024. These payments were reported across 218 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,641).
As a Medicare-enrolled provider, Schulman has provided services to 5,273 Medicare beneficiaries, totaling 7,124 services with total Medicare billing of $876,177. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Great Neck, NY
- Active Since 11/29/2006
- Last Updated 05/03/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134296866
Products in Payments
- RINVOQ (Biological) $605.60
- XIFAXAN (Drug) $521.51
- Sucraid (Drug) $515.85
- ZEPOSIA (Drug) $350.74
- SKYRIZI (Biological) $244.75
- Humira (Biological) $189.40
- REMICADE (Biological) $162.50
- Linzess (Drug) $157.31
- LINZESS (Drug) $154.22
- OCALIVA (Drug) $140.80
- STELARA (Biological) $127.20
- Creon (Drug) $125.00
- VELSIPITY (Drug) $125.00
- XEOMIN (Biological) $125.00
- IBSRELA (Drug) $97.15
- IDACIO (Biological) $95.00
- XIFAXANIBSD (Drug) $94.04
- CREON (Drug) $73.90
- VIBERZI (Drug) $50.49
- VOQUEZNA (Drug) $49.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Internal Medicine $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Internal Medicine $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Internal Medicine $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Internal Medicine $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
Internal Medicine $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163
Internal Medicine $15,163